Artielle Immunotherapeutics
Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Artielle Immunotherapeutics Information
Geographic Data
Address: 400 S El Camino Real Suite 1200
City: San Mateo
State: CA
Zip: 94402
Country: US
Financial Info
Stage:
convertible note
Raised Last:
$186k
Raised Total:$11M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Artielle ImmunoTherapeutics, Inc., a biopharmaceutical company, develops recombinant T-cell receptor ligands (RTLs) to treat T-cell mediated inflammatory diseases. It develops RTL1000, a compound for the treatment of multiple sclerosis. The company focuses on the development of therapeutics for the treatment of autoimmune diseases that include multiple sclerosis, celiac disease, type 1 diabetes, rheumatoid arthritis, uveitis, stroke, optic neuritis, and other diseases. Artielle ImmunoTherapeutics, Inc. was founded in 2004 and is based in Tigard, Oregon.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2004 | Series A | 4 | $11M |
Northwest Technology Ventures Pelion Venture Partners Sanderling Ventures Tenex Greenhouse Ventures Northwest Technology Ventures Pelion Venture Partners Sanderling Ventures Tenex Greenhouse Ventures |
4/2010 | Convertible Note | $185.7k |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
